Rafeifadattis KF, Rizkillah N, Aulia NN, Apriani V, Sudarjat H. Empaglifozin In Type 2 Diabetes: From Mechanisms To Clinical Practice – A Comprehensive Review Of Monotherapy, Combinations, And Therapeutic Advantages. JN [Internet]. 2025 Nov. 21 [cited 2025 Dec. 5];10(1):182-95. Available from: https://journal.universitaspahlawan.ac.id/index.php/ners/article/view/51869